EUVIMEDEUVIMED entdecken
Crossref

64 Cu-Labeled Bioorthogonal Probe for Targeted Positron Emission Tomography Imaging of Malignant Melanoma

Boreum Song, Dagyeong Hong, Chaewon Lee, Yejin Seo, Eunsu Kim, Wookyeong Jeong, Seyeon Choi, Chang Sup Lee, Seong-Young Kwon, Dong-Yeon Kim iD, Ayoung Pyo

Molecular Pharmaceutics · 06.07.2026 · 23 (7) · 3769-3778

DOI: 10.1021/acs.molpharmaceut.6c00247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 06.06.2026. Verfasst von Boreum Song und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Research Institute of Pharmaceutical Science, Gyeongsang National University, Jinju 52828, Republic of Korea. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Copper Radioisotopes, Melanoma, Melanoma, Experimental. Die Arbeit nennt 71 Literaturangaben. Gefördert von: Korea Drug Development Fund, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyCopper RadioisotopesMelanomaMelanoma, ExperimentalRadiopharmaceuticalsSkin NeoplasmsAnimalsMiceMice, Inbred C57BLCell Line, TumorTissue DistributionHumansChelating AgentsBenzamidesMelanins

Stichwörter der Autor:innen

64Cu chelationbenzamide derivativebioorthogonal probemalignant melanomatheranostics

Substanzen

Copper RadioisotopesRadiopharmaceuticalsCopper-64Chelating AgentsBenzamidesMelanins

Autor:innen und Institutionen

  • College of Pharmacy and Research Institute of Pharmaceutical Science, Gyeongsang National University, Jinju 52828, Republic of Korea.
  • CNCure Biotech, Hwasun 58128, Republic of Korea.
  • Department of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, Hwasun 58128, Republic of Korea.

ORCID-Profile: Dong-Yeon Kim

Förderung

  • Korea Drug Development Fund
  • National Research Foundation of Korea

Zitieren

APA

Song, B., Hong, D., Lee, C., Seo, Y., Kim, E., Jeong, W., Choi, S., Lee, C. S., Kwon, S. Y., Kim, D. Y., & Pyo, A. (2026). 64 Cu-Labeled Bioorthogonal Probe for Targeted Positron Emission Tomography Imaging of Malignant Melanoma. Molecular Pharmaceutics, 23(7), 3769-3778. https://doi.org/10.1021/acs.molpharmaceut.6c00247

Vancouver

Song B, Hong D, Lee C, Seo Y, Kim E, Jeong W, et al. 64 Cu-Labeled Bioorthogonal Probe for Targeted Positron Emission Tomography Imaging of Malignant Melanoma. Molecular Pharmaceutics. 2026;23(7):3769-3778. doi:10.1021/acs.molpharmaceut.6c00247

BibTeX
@article{Song2026,
  author = {Song, Boreum and Hong, Dagyeong and Lee, Chaewon and Seo, Yejin and Kim, Eunsu and Jeong, Wookyeong and Choi, Seyeon and Lee, Chang Sup and Kwon, Seong-Young and Kim, Dong-Yeon and Pyo, Ayoung},
  title = {64 Cu-Labeled Bioorthogonal Probe for Targeted Positron Emission Tomography Imaging of Malignant Melanoma},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {7},
  pages = {3769--3778},
  doi = {10.1021/acs.molpharmaceut.6c00247}
}
Kostenlos starten →